Announcements Trials
Browse Landscape

Status

Completed 3Recruiting 2Active not recruiting 2Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gynecologic 2

Conditions

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Endometrial Neoplasms 1

Interventions

Surveys and Questionnaires 39Blood Specimen Collection 23Specimen Handling 14Radiotherapy 12Surgical Procedures, Operative 10Magnetic Resonance Spectroscopy 10Interviews as Topic 10Observation 9Drug Therapy 9Data Collection 8Immunotherapy 7Watchful Waiting 5Tomography, X-Ray Computed 5Radiosurgery 5Nivolumab 5Mental Status and Dementia Tests 5Mastectomy, Segmental 5Immune Checkpoint Inhibitors 5Biopsy 5ribociclib 4palbociclib 4lorlatinib 4Therapeutics 4Positron Emission Tomography Computed Tomography 4Magnetic Resonance Imaging 4Ipilimumab 4High-Throughput Nucleotide Sequencing 4Hepatectomy 4Echocardiography 4Bevacizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Observational × Hysterectomy × Clear all
NCT04604613 2026-03-09

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

M.D. Anderson Cancer Center

Active not recruiting
518 enrolled
Gynecologic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

NCT06800677 2025-01-30

BioMEC

University of Manchester

Active not recruiting
200 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡